-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rituximab Biosimilar in Follicular Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Rituximab Biosimilar in Follicular Lymphoma Drug Details:Rituximab biosimilar is under development for the treatment of non-Hodgkin...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sym-024 in Metastatic Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Sym-024 in Metastatic Colorectal Cancer Drug Details: Sym-024 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rituximab Biosimilar in Chronic Lymphocytic Leukemia (CLL)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Rituximab Biosimilar in Chronic Lymphocytic Leukemia (CLL) Drug Details: Rituximab biosimilar is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dalpiciclib in Nasopharyngeal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Dalpiciclib in Nasopharyngeal CancerDrug Details:Dalpiciclib isethionate (Erlikon) is a hypoglycemic agent. It is formulated as tablets...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Acazicolcept in Sicca Syndrome (Sjogren)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Acazicolcept in Sicca Syndrome (Sjogren)Drug Details:Acazicolcept is under development for the treatment of multiple sclerosis, arthritis,...
-
Company Profile
![]()
Apotex Inc – Company Profile
Apotex Inc (Apotex) produces and markets generic pharmaceuticals. The company also offers biosimilars, active pharmaceutical ingredients and consumer products. It carries out the research, development, manufacture, and distribution of non-prescription and private label medicines, fine chemicals, and disposable plastics for medical use. The company has R&D facilities in Montreal, Richmond Hill, Brantford, Windsor, Winnipeg, Toronto, Etobicoke, Mississauga, London, Calgary, and Vancouver. It serves patients, healthcare providers and payers, governments, and other pharmaceutical manufacturers. The company operates through subsidiaries, joint ventures...
Add to Basket -
Product Insights
![]()
Restless Legs Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The restless legs syndrome clinical trial market research report provides an overview of the restless legs syndrome clinical trials scenario. The report provides top-line data relating to the clinical trials on restless legs syndrome. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
![]()
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Chronic lymphocytic leukemia (CLL) is a type of cancer that starts from white blood cells (called lymphocytes) in the bone marrow. It then invades the blood. Symptoms of CLL include abnormal bruising (if platelets are low), fever, infections that keep coming back (recur), loss of appetite or becoming full too quickly (early satiety), and weight loss. Treatment options include surgery, radiation therapy, chemotherapy, or a combination of methods. The CLL pipeline drugs market research report provides comprehensive information on the...
-
Product Insights
![]()
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Symptoms may include night sweats, fever and chills that come and go, itching, putting pressure on the windpipe (trachea) or other airways, abdominal pain or swelling, leading to loss of appetite, constipation, nausea, and vomiting and headache, concentration problems, personality changes, or seizures if cancer affects the brain. Treatment includes surgery,...
-
Product Insights
![]()
Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Febrile Neutropenia clinical trial market research report provides an overview and top-line data relating to the clinical trials on Febrile Neutropenia. The report includes an overview of trials count and their average enrollment in top countries conducted globally. It also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on the number of...
-
Product Insights
![]()
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gastric Cancer signs and symptoms include fatigue, stomach pain, vomiting, weight loss that is unintentional, feeling bloated after eating, heartburn and indigestion. Treatment includes surgery, chemotherapy, and radiation therapy. The Gastric Cancer pipeline drugs market research report provides an analysis of the Gastric Cancer drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and...
-
Product Insights
![]()
Gastric Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gastric Ulcers Drugs in Development Report Overview A gastric ulcer is a painful sore or ulcer in the lining of the stomach. The most common cause of gastric ulcer is Helicobacter pylori bacterial infection. Symptoms include pain, bloating, retching, nausea or vomiting, and unexplained weight loss. Predisposing factors include smoking and alcoholism. Treatment includes antibiotics and antacids. The Gastric Ulcers pipeline drugs market research report provides comprehensive information on the therapeutics under development for Gastric Ulcers, complete with analysis by...
-
Product Insights
![]()
Chemotherapy Induced Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Chemotherapy induced neutropenia pipeline market research report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Neutropenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and...
-
Sector Analysis
![]()
Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition
According to the Global Data’s Drugs database, it indicates that maximum of the marketed drugs is found to be small molecules, despite many of the prominent contract manufacturing organizations (CMOs) investing in advanced therapy medicinal product (ATMP) capabilities in recent years and an increasing use of biologic APIs in both the pipeline and among marketed drugs. With the increase in high potency small molecule APIs, has been driven by the rise of oncology pipeline drugs coupled with small or virtual...
-
Product Insights
![]()
Neutropenia – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report provides data on the neutropenia clinical trial scenario. This report provides top-line data relating to the clinical trials on Neutropenia. The report includes an overview of trials count and their average enrolment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on the...
-
Product Insights
![]()
Herpes Labialis (Oral Herpes) – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Herpes Labialis (Oral Herpes) - Global Clinical Trials Review, H2, 2021" provides an overview of Herpes Labialis (Oral Herpes) Clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Product Insights
![]()
Herpes Labialis (Oral Herpes) Disease – Global Clinical Trials Review, H2 2020
GlobalData's clinical trial report, “Herpes Labialis (Oral Herpes) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Herpes Labialis (Oral Herpes) Clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Product Insights
![]()
Neutropenia Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Neutropenia Global Clinical Trials Review, H1, 2018" provides an overview of Neutropenia clinical trials scenario. This report provides top line data relating to the clinical trials on Neutropenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
![]()
Dry Eye Syndrome: Global Drug Forecast and Market Analysis to 2026
Dry Eye Syndrome (DES) is a multifactorial disease of the tears and ocular surface that causes ocular discomfort, visual disturbances, and tear film instability, which can potentially damage the ocular surface. With a rapidly accelerating worldwide prevalence and the limited treatment options available, there is a growing pressure for new therapies and curative treatment for DES patients. Significant efforts are being made to develop a new treatment for DES, as current pharmacologic management is known to only provide temporary symptomatic...
-
Product Insights
![]()
Poisoning Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Poisoning Global Clinical Trials Review, H1, 2018" provides an overview of Poisoning clinical trials scenario. This report provides top line data relating to the clinical trials on Poisoning. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.